Prurigo Nodularis - 1 Studies Found
| Completed |
: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) : Prurigo Nodularis : 2025-07-31 : Ruxolitinib cream 1.5% twice daily (BID) during the continuous and open label treatment period. |